Neogen (NASDAQ:NEOG) Shares Gap Down – Should You Sell?

Neogen Corporation (NASDAQ:NEOG) gapped down prior to trading on Thursday . The stock had previously closed at $10.34, but opened at $9.20. Neogen shares last traded at $10.16, with a volume of 1,427,083 shares changing hands.

Key Headlines Impacting Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Q3 beat on both EPS and revenue versus consensus (EPS $0.09 vs. $0.04 est.; revenue $211.2M vs. $204.6M est.), showing the company outperformed near-term Street expectations. Neogen (NEOG) Beats Q3 Earnings and Revenue Estimates MarketBeat Earnings Release
• Neutral Sentiment: Company released the full Q3 press release, slide deck and hosted a conference call outlining a strategic transformation and updated FY-2026 guidance — useful for clarifying drivers but not decisive on its own. Neogen Reports Third Quarter Fiscal Year 2026 Financial Results Slide Deck
• Neutral Sentiment: Corporate governance update: appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer — likely stability/controls positive but not material short-term. Appointment Announcement
• Negative Sentiment: Despite the beat, investors focused on weakening profitability: revenue was down ~4.4% YoY and the company reported a materially negative net margin (reported -68% in the release), suggesting one-time charges or restructuring hit results and raising questions about near-term profitability recovery. MarketBeat Earnings Details
• Negative Sentiment: Sector/segment drag: coverage (Barron’s) notes the Animal Safety business is facing “third‑party” setbacks that are weighing on results and investor confidence — this helps explain why the stock fell despite the top-line and EPS beats. Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren’t Helping.

Wall Street Analyst Weigh In

A number of research firms have commented on NEOG. Wall Street Zen raised shares of Neogen from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Piper Sandler reaffirmed a “neutral” rating and issued a $10.00 target price (up from $6.50) on shares of Neogen in a research report on Monday, January 12th. CJS Securities raised shares of Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research report on Wednesday, December 10th. Guggenheim reissued a “buy” rating and set a $12.00 price target (up from $8.00) on shares of Neogen in a research report on Friday, January 9th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Neogen in a research report on Monday, December 29th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Neogen presently has a consensus rating of “Hold” and an average price target of $10.67.

Neogen Price Performance

The stock’s 50 day moving average is $10.09 and its two-hundred day moving average is $7.97. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.91 and a quick ratio of 2.80. The stock has a market capitalization of $2.22 billion, a PE ratio of -3.68 and a beta of 1.97.

Neogen (NASDAQ:NEOG) last released its earnings results on Thursday, April 9th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.05. Neogen had a negative net margin of 68.47% and a positive return on equity of 2.14%. The firm had revenue of $211.20 million for the quarter, compared to analyst estimates of $204.62 million. The firm’s revenue was down 4.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Neogen Corporation will post 0.38 earnings per share for the current fiscal year.

Institutional Trading of Neogen

A number of large investors have recently made changes to their positions in NEOG. AQR Capital Management LLC increased its stake in shares of Neogen by 217.0% during the first quarter. AQR Capital Management LLC now owns 52,410 shares of the company’s stock worth $443,000 after buying an additional 35,878 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Neogen by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company’s stock valued at $1,125,000 after purchasing an additional 5,638 shares during the last quarter. Jones Financial Companies Lllp increased its stake in Neogen by 5,687.3% in the first quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company’s stock valued at $290,000 after purchasing an additional 32,816 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Neogen by 14.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company’s stock valued at $14,553,000 after purchasing an additional 209,990 shares during the last quarter. Finally, United Services Automobile Association purchased a new position in Neogen in the first quarter valued at approximately $112,000. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.